An exploration of patient-reported symptoms in systemic lupus erythematosus and the relationship to health-related quality of life

References

• Swaak AJG. Systemic lupus erythematosus: clinical features in patients with a disease duration of over 10 years, first evaluation. Rheumatology 1999;10:953–8.
   Google Scholar
• Tench CM, McCurdie I, White PD, D’Cruz DP. The prevalence and associations of fatigue in systemic lupus erythematosus. Rheumatology (Oxford) 2000;11:1249–54.
   Google Scholar
• McElhone K, Abbott J, Gray J, Williams A, Teh LS. Patient perspective of systemic lupus erythematosus in relation to health-related quality of life concepts: a qualitative study. Lupus 2010;14:1640–7.
   Google Scholar
• Stamm TA, Bauernfeind B, Coenen M, Feierl E, Mathis M, Stucki G, . Concepts important to persons with systemic lupus erythematosus and their coverage by standard measures of disease activity and health status. Arthritis Rheum 2007;7:1287–95.
   Google Scholar
• Haq I, Isenberg DA. How does one assess and monitor patients with systemic lupus erythematosus in daily clinical practice? Best Pract Res Clin Rheumatol 2002;2:181–94.
   Google Scholar
• Kirwan JR, Newman S, Tugwell PS, Wells GA. Patient perspective on outcomes in rheumatology – a position paper for OMERACT 9. J Rheumatol 2009;9:2067–70.
   Google Scholar
• Grootscholten C, Ligtenberg G, Derksen RH, Schreurs KM, de Glas-Vos JW, Hagen EC, . Health-related quality of life in patients with systemic lupus erythematosus: development and validation of a lupus specific symptom checklist. Qual Life Res 2003;6:635–44.
   Google Scholar
• Freire EA, Guimaraes E, Maia I, Ciconelli RM. Systemic lupus erythematosus symptom checklist cross-cultural adaptation to Brazilian Portuguese language and reliability evaluation. Acta Reumatol Port 2007;4:341–4.
   Google Scholar
• Grootscholten C, Snoek FJ, Bijl M, van Houwelingen HC, Derksen RH, Berden JH. Health-related quality of life and treatment burden in patients with proliferative lupus nephritis treated with cyclo- phosphamide or azathioprine/methylprednisolone in a randomized controlled trial. J Rheumatol 2007;8:1699–707.
   Google Scholar
• Robinson D Jr, Aguilar D, Schoenwetter M, Dubois R, Russak S, Ramsey-Goldman R, . Impact of systemic lupus erythematosus on health, family, and work: the patient perspective. Arthritis Care Res (Hoboken) 2010;2:266–73.
   Google Scholar
• Aggarwal R, Wilke CT, Pickard AS, Vats V, Mikolaitis R, Fogg L, . Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosus. J Rheumatol 2009;6:1209–16.
   Google Scholar
• Kiani AN, Petri M. Quality-of-life measurements versus disease activity in systemic lupus erythematosus. Curr Rheumatol Rep 2010;4:250–8.
   Google Scholar
• Yee CS, McElhone K, Teh LS, Gordon C. Assessment of disease activity and quality of life in systemic lupus erythematosus – new aspects. Best Pract Res Clin Rheumatol 2009;4:457–67.
   Google Scholar
• McElhone K, Abbott J, Teh LS. A review of health related quality of life in systemic lupus erythematosus. Lupus 2006;10:633–43.
   Google Scholar
• Wolfe F, Michaud K, Li T, Katz RS. EQ-5D and SF-36 quality of life measures in systemic lupus erythematosus: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, and fibromyalgia. J Rheumatol 2010;2:296–304.
   Google Scholar
• Da Costa D, Dobkin PL, Fitzcharles MA, Fortin PR, Beaulieu A, Zummer M, . Determinants of health status in fibromyalgia: a comparative study with systemic lupus erythematosus. J Rheumatol 2000;2:365–72.
   Google Scholar
• Gilboe IM, Kvien TK, Husby G. Health status in systemic lupus erythematosus compared to rheumatoid arthritis and healthy controls. J Rheumatol 1999;8:1694–700.
   Google Scholar
• Almehed K, Carlsten H, Forsblad-d’Elia H. Health-related quality of life in systemic lupus erythematosus and its association with disease and work disability. Scand J Rheumatol 2010;1:58–62.
   Google Scholar
• Mok CC, Ho LY, Cheung MY, Yu KL, To CH. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study. Scand J Rheumatol 2009;2:121–7.
   Google Scholar
• Bauernfeind B, Aringer M, Prodinger B, Kirchberger I, Machold K, Smolen J, . Identification of relevant concepts of functioning in daily life in people with systemic lupus erythematosus: a patient Delphi exercise. Arthritis Rheum 2009;1:21–8.
   Google Scholar
• Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, . The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;11:1271–7.
   Google Scholar
• Persson LO, Karlsson J, Bengtsson C, Steen B, Sullivan M. The Swedish SF-36 Health Survey II. Evaluation of clinical validity: results from population studies of elderly and women in Gothenborg. J Clin Epidemiol 1998;11:1095–103.
   Google Scholar
• Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002;2:69–77.
   Google Scholar
• Lisspers J, Nygren A, Soderman E. Hospital Anxiety and Depression Scale (HAD): some psychometric data for a Swedish sample. Acta Psychiatr Scand 1997;4:281–6.
   Google Scholar
• Liang MH, Socher SA, Roberts WN, Esdaile JM. Measurement of systemic lupus erythematosus activity in clinical research. Arthritis Rheum 1988;7:817–25.
   Google Scholar
• Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989;9:1107–18.
   Google Scholar
• Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992;6:630–40.
   Google Scholar
• Chang E, Abrahamowicz M, Ferland D, Fortin PR. Comparison of the responsiveness of lupus disease activity measures to changes in systemic lupus erythematosus activity relevant to patients and physicians. J Clin Epidemiol 2002;5:488–97.
   Google Scholar
• Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, . The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumato- logy damage index for systemic lupus erythematosus. Arthritis Rheum 1996;3:363–9.
   Google Scholar
• Gladman DD, Urowitz MB, Goldsmith CH, Fortin P, Ginzler E, Gordon C, . The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum 1997;5:809–13.
   Google Scholar
• Tishelman C, Lovgren M, Broberger E, Hamberg K, Sprangers MA. Are the most distressing concerns of patients with inoperable lung cancer adequately assessed? A mixed-methods analysis. J Clin Oncol 2010;11:1942–9.
   Google Scholar
• Brennan P, Silman A. Statistical methods for assessing observer variability in clinical measures. Br Med J 1992;6840:1491–4.
   Google Scholar
• Gunnarsson I, van Vollenhoven RF. Biologicals for the treatment of systemic lupus erythematosus? Ann Med. Published online 15 April 2011. doi:10.3109/07853890.2011.561362.
   Google Scholar
• Kalunian K, Joan TM. New directions in the treatment of systemic lupus erythematosus. Curr Med Res Opin 2009;6:1501–14.
   Google Scholar
• Strand V, Gladman D, Isenberg D, Petri M, Smolen J, Tugwell P. Endpoints: consensus recommendations from OMERACT IV. Outcome Measures in Rheumatology. Lupus 2000;5: 322–7.
   Google Scholar
• Thumboo J, Strand V. Health-related quality of life in patients with systemic lupus erythematosus: an update. Ann Acad Med Singapore 2007;2:115–22.
   Google Scholar
• Leong KP, Kong KO, Thong BY, Koh ET, Lian TY, Teh CL, . Development and preliminary validation of a systemic lupus erythematosus-specific quality-of-life instrument (SLEQOL). Rheumatology (Oxford) 2005;10:1267–76.
   Google Scholar
• McElhone K, Abbott J, Shelmerdine J, Bruce IN, Ahmad Y, Gordon C, . Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus. Arthritis Rheum 2007;6:972–9.
   Google Scholar
• Kwoh CK, Ibrahim SA. Rheumatology patient and physician concordance with respect to important health and symptom status outcomes. Arthritis Rheum 2001;4:372–7.
   Google Scholar
• Leong KP, Chong EY, Kong KO, Chan SP, Thong BY, Lian TY, . Discordant assessment of lupus activity between patients and their physicians: the Singapore experience. Lupus 2010;1:100–6.
   Google Scholar
• Yen JC, Abrahamowicz M, Dobkin PL, Clarke AE, Battista RN, Fortin PR. Determinants of discordance between patients and physicians in their assessment of lupus disease activity. J Rheumatol 2003;9:1967–76.
   Google Scholar
• Neville C, Clarke AE, Joseph L, Belisle P, Ferland D, Fortin PR. Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity. J Rheumatol 2000;3:675–9.
   Google Scholar